BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 12900389)

  • 1. Loss of active MEK1-ERK1/2 restores epithelial phenotype and morphogenesis in transdifferentiated MDCK cells.
    Schramek H; Feifel E; Marschitz I; Golochtchapova N; Gstraunthaler G; Montesano R
    Am J Physiol Cell Physiol; 2003 Sep; 285(3):C652-61. PubMed ID: 12900389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Constitutively active mitogen-activated protein kinase kinase MEK1 disrupts morphogenesis and induces an invasive phenotype in Madin-Darby canine kidney epithelial cells.
    Montesano R; Soriano JV; Hosseini G; Pepper MS; Schramek H
    Cell Growth Differ; 1999 May; 10(5):317-32. PubMed ID: 10359013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Constitutively active mutant of the mitogen-activated protein kinase kinase MEK1 induces epithelial dedifferentiation and growth inhibition in madin-darby canine kidney-C7 cells.
    Schramek H; Feifel E; Healy E; Pollack V
    J Biol Chem; 1997 Apr; 272(17):11426-33. PubMed ID: 9111053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of cell-cell adhesion proteins and cyclin D in MEK1-transdifferentiated MDCK cells.
    Marschitz I; Lechner J; Mosser I; Dander M; Montesano R; Schramek H
    Am J Physiol Cell Physiol; 2000 Nov; 279(5):C1472-82. PubMed ID: 11029295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Docking sites on mitogen-activated protein kinase (MAPK) kinases, MAPK phosphatases and the Elk-1 transcription factor compete for MAPK binding and are crucial for enzymic activity.
    Bardwell AJ; Abdollahi M; Bardwell L
    Biochem J; 2003 Mar; 370(Pt 3):1077-85. PubMed ID: 12529172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p38 mitogen-activated protein kinase-dependent activation of protein phosphatases 1 and 2A inhibits MEK1 and MEK2 activity and collagenase 1 (MMP-1) gene expression.
    Westermarck J; Li SP; Kallunki T; Han J; Kähäri VM
    Mol Cell Biol; 2001 Apr; 21(7):2373-83. PubMed ID: 11259586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel point mutations in ERK2 that selectively disrupt binding to MEK1.
    Robinson FL; Whitehurst AW; Raman M; Cobb MH
    J Biol Chem; 2002 Apr; 277(17):14844-52. PubMed ID: 11823456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MEK1/2-ERK1/2 mediates alpha1-adrenergic receptor-stimulated hypertrophy in adult rat ventricular myocytes.
    Xiao L; Pimental DR; Amin JK; Singh K; Sawyer DB; Colucci WS
    J Mol Cell Cardiol; 2001 Apr; 33(4):779-87. PubMed ID: 11273730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and activity of the signaling molecules for mitogen-activated protein kinase pathways in human, bovine, and rat lenses.
    Li DW; Liu JP; Wang J; Mao YW; Hou LH
    Invest Ophthalmol Vis Sci; 2003 Dec; 44(12):5277-86. PubMed ID: 14638727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of cytokeratin expression and formation of actin stress fibers in dedifferentiated MDCK-C7 cell lines.
    Pollack V; Scheiber K; Pfaller W; Schramek H
    Biochem Biophys Res Commun; 1997 Dec; 241(2):541-7. PubMed ID: 9425307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential regulation of mitogen-activated protein/ERK kinase (MEK)1 and MEK2 and activation by a Ras-independent mechanism.
    Xu S; Khoo S; Dang A; Witt S; Do V; Zhen E; Schaefer EM; Cobb MH
    Mol Endocrinol; 1997 Oct; 11(11):1618-25. PubMed ID: 9328344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High expression of PKC-MAPK pathway mRNAs correlates with glomerular lesions in human diabetic nephropathy.
    Toyoda M; Suzuki D; Honma M; Uehara G; Sakai T; Umezono T; Sakai H
    Kidney Int; 2004 Sep; 66(3):1107-14. PubMed ID: 15327405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ochratoxin A-induced stimulation of extracellular signal-regulated kinases 1/2 is associated with Madin-Darby canine kidney-C7 cell dedifferentiation.
    Schramek H; Wilflingseder D; Pollack V; Freudinger R; Mildenberger S; Gekle M
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1460-8. PubMed ID: 9400022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucose-dependent insulinotropic polypeptide activates the Raf-Mek1/2-ERK1/2 module via a cyclic AMP/cAMP-dependent protein kinase/Rap1-mediated pathway.
    Ehses JA; Pelech SL; Pederson RA; McIntosh CH
    J Biol Chem; 2002 Oct; 277(40):37088-97. PubMed ID: 12138104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression and activation of MAP kinases in dedifferentiated MDCK-focus cells.
    Schramek H; Schumacher M; Wilflingseder D; Oberleithner H; Pfaller W
    Am J Physiol; 1997 Feb; 272(2 Pt 1):C383-91. PubMed ID: 9124279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Properties of MEKs, the kinases that phosphorylate and activate the extracellular signal-regulated kinases.
    Zheng CF; Guan KL
    J Biol Chem; 1993 Nov; 268(32):23933-9. PubMed ID: 8226933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of extracellular signal-regulated kinases, NF-kappa B, and cyclic adenosine 5'-monophosphate response element-binding protein in lung neutrophils occurs by differing mechanisms after hemorrhage or endotoxemia.
    Abraham E; Arcaroli J; Shenkar R
    J Immunol; 2001 Jan; 166(1):522-30. PubMed ID: 11123332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. cAMP potentiates H(2)O(2)-induced ERK1/2 phosphorylation without the requirement for MEK1/2 phosphorylation.
    Lee K; Esselman WJ
    Cell Signal; 2001 Sep; 13(9):645-52. PubMed ID: 11495722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Up-regulation of mitogen-activated protein kinases ERK1/2 and MEK1/2 is associated with the progression of neurofibrillary degeneration in Alzheimer's disease.
    Pei JJ; Braak H; An WL; Winblad B; Cowburn RF; Iqbal K; Grundke-Iqbal I
    Brain Res Mol Brain Res; 2002 Dec; 109(1-2):45-55. PubMed ID: 12531514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rac-PAK signaling stimulates extracellular signal-regulated kinase (ERK) activation by regulating formation of MEK1-ERK complexes.
    Eblen ST; Slack JK; Weber MJ; Catling AD
    Mol Cell Biol; 2002 Sep; 22(17):6023-33. PubMed ID: 12167697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.